A Peek Into The Markets: US Stock Futures Mixed; Inflation Data In Focus
Pre-open movers
U.S. stock futures traded mixed in early pre-market trade after the Dow Jones dropped by more than 600 points in the previous session. Investors are awaiting data on consumer prices for the month of May.
Fake Urine To Pass A Drug Test? It’s A Thing And Michigan Wants To Stop It, Here’s What’s Happening
Cannabis, which can be detected by urine screens for up to a month after consumption, has been legal for adults in Michigan since 2018 although drug testing for certain jobs persists...as do myriad methods to get around it.
B of A Securities Maintains Buy on Quest Diagnostics, Lowers Price Target to $163
B of A Securities analyst Derik De Bruin maintains Quest Diagnostics (NYSE:DGX) with a Buy and lowers the price target from $166 to $163.
Quest Diagnostics’ COVID-19 Testing Sales Decline 28% In Q1; Lifts FY22 EPS Guidance
Quest Diagnostics Inc (NYSE:DGX) posted a better-than-expected Q1 FY22 adjusted EPS of $3.22, down 14.4% Y/Y, beating the consensus of…
Quest Diagnostics’s Earnings: A Preview
Quest Diagnostics (NYSE:DGX) is set to give its latest quarterly earnings report on Thursday, 2022-04-21. Here's what investors need to know before the announcement.
Analysts estimate that Quest Diagnostics will report an earnings per share (EPS) of $2.97.
Analyst Ratings For Quest Diagnostics
Quest Diagnostics (NYSE:DGX) has observed the following analyst ratings within the last quarter:
GBS: Institutional Review Board Approval for Glucose
By John Vandermosten, CFA
NASDAQ:GBS
READ THE FULL GBS RESEARCH REPORT
